RMD vs. DXCM
Compare and contrast key facts about ResMed Inc. (RMD) and DexCom, Inc. (DXCM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RMD or DXCM.
Key characteristics
| RMD | DXCM | |
|---|---|---|
| YTD Return | 48.08% | -43.62% |
| 1Y Return | 77.62% | -24.29% |
| 3Y Return (Ann) | -0.31% | -24.04% |
| 5Y Return (Ann) | 12.87% | 7.17% |
| 10Y Return (Ann) | 18.93% | 18.11% |
| Sharpe Ratio | 1.92 | -0.45 |
| Sortino Ratio | 2.76 | -0.21 |
| Omega Ratio | 1.40 | 0.96 |
| Calmar Ratio | 1.40 | -0.41 |
| Martin Ratio | 13.76 | -0.86 |
| Ulcer Index | 5.18% | 28.57% |
| Daily Std Dev | 37.09% | 54.39% |
| Max Drawdown | -61.60% | -94.61% |
| Current Drawdown | -12.68% | -57.03% |
Fundamentals
| RMD | DXCM | |
|---|---|---|
| Market Cap | $37.05B | $27.33B |
| EPS | $7.65 | $1.67 |
| PE Ratio | 32.99 | 41.89 |
| PEG Ratio | 1.92 | 1.08 |
| Total Revenue (TTM) | $4.81B | $3.95B |
| Gross Profit (TTM) | $2.75B | $2.44B |
| EBITDA (TTM) | $1.76B | $940.70M |
Correlation
The correlation between RMD and DXCM is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
RMD vs. DXCM - Performance Comparison
In the year-to-date period, RMD achieves a 48.08% return, which is significantly higher than DXCM's -43.62% return. Both investments have delivered pretty close results over the past 10 years, with RMD having a 18.93% annualized return and DXCM not far behind at 18.11%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RMD vs. DXCM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RMD vs. DXCM - Dividend Comparison
RMD's dividend yield for the trailing twelve months is around 0.80%, while DXCM has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RMD ResMed Inc. | 0.80% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% | 1.89% | 1.78% |
DXCM DexCom, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
RMD vs. DXCM - Drawdown Comparison
The maximum RMD drawdown since its inception was -61.60%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for RMD and DXCM. For additional features, visit the drawdowns tool.
Volatility
RMD vs. DXCM - Volatility Comparison
ResMed Inc. (RMD) and DexCom, Inc. (DXCM) have volatilities of 8.56% and 8.55%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RMD vs. DXCM - Financials Comparison
This section allows you to compare key financial metrics between ResMed Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities